SUNHO BIO-B (02898) announced its interim performance, with a net loss of 38.199 million yuan, a year-on-year increase of 5.88%.
Shenghe Biotech-B (02898) announces its mid-term performance for 2025, with other income of 5.035 million yuan, a year-on-year growth of...
SUNHO BIO-B(02898) announced its mid-term performance for 2025, with other income of 5.035 million yuan, a year-on-year increase of 182.55%; a net loss of 38.199 million yuan, a year-on-year increase of 5.88%; and a loss per share of 0.25 yuan.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
